[1. Coffey S, Cairns BJ, Iung B. The modern epidemiology of heart valve disease. Heart. 2016 Jan;102(1):75-85.10.1136/heartjnl-2014-30702026541169]Search in Google Scholar
[2. Cribier A. Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey. Arch Cardiovasc Dis. 2012 Mar;105(3):146-52.10.1016/j.acvd.2012.01.00522520797]Search in Google Scholar
[3. Cullen MW, Cabalka AK, Alli OO, Pislaru SV, Sorajja P, Nkomo VT, et al. Transvenous, antegrade Melody valve-in-valve implantation for bioprosthetic mitral and tricuspid valve dysfunction: a case series in children and adults. JACC Cardiovasc Interv. 2013 Jun;6(6):598-605.10.1016/j.jcin.2013.02.01023683739]Search in Google Scholar
[4. Schillinger W, Senges J. (TRAMI (Transcatheter Mitral Valve Interventions) register. The German mitral register). Herz. 2013 Aug;38(5):453-9.10.1007/s00059-013-3858-323797374]Search in Google Scholar
[5. Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012 Oct;27(10):1361-7.10.1007/s11606-012-2077-6344567622618581]Search in Google Scholar
[6. Friedewald VE, Bonow RO, Borer JS, Carabello BA, Kleine PP, Akins CW, et al. The Editor’s Roundtable: cardiac valve surgery. Am J Cardiol. 2007 May 1;99(9):1269-78.10.1016/j.amjcard.2007.02.04017478156]Search in Google Scholar
[7. Mikos AG, Herring SW, Ochareon P, Elisseeff J, Lu HH, Kandel R, et al. Engineering complex tissues. Tissue Eng. 2006 Dec;12(12):3307-39.10.1089/ten.2006.12.3307282121017518671]Search in Google Scholar
[8. Yacoub MH, Takkenberg JJ. Will heart valve tissue engineering change the world? Nat Clin Pract Cardiovasc Med. 2005 Feb;2(2):60-1.10.1038/ncpcardio011216265355]Search in Google Scholar
[9. van Geldorp MW, Eric Jamieson WR, Kappetein AP, Ye J, Fradet GJ, Eijkemans MJ, et al. Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg. 2009 Apr;137(4):881-6, 6e1-5.10.1016/j.jtcvs.2008.09.028]Search in Google Scholar
[10. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017 Sep 21;38(36):2739-91.]Search in Google Scholar
[11. Hoffmann G, Lutter G, Cremer J. Durability of bioprosthetic cardiac valves. Dtsch Arztebl Int. 2008 Feb;105(8):143-8.10.3238/arztebl.2008.0143269673819633780]Search in Google Scholar
[12. Langer R, Vacanti JP. Tissue engineering. Science. 1993 May 14;260(5110):920-6.10.1126/science.84935298493529]Search in Google Scholar
[13. Sodian R, Hoerstrup SP, Sperling JS, Daebritz S, Martin DP, Moran AM, et al. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation. 2000 Nov 7;102(19 Suppl 3):III22-9.10.1161/01.CIR.102.suppl_3.III-22]Search in Google Scholar
[14. Shinoka T, Ma PX, Shum-Tim D, Breuer CK, Cusick RA, Zund G, et al. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation. 1996 Nov 1;94(9 Suppl):II164-8.]Search in Google Scholar
[15. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, et al. Functional living trileaflet heart valves grown in vitro. Circulation. 2000 Nov 7;102(19 Suppl 3):Iii44-9.10.1161/01.CIR.102.suppl_3.III-44]Search in Google Scholar
[16. Shinoka T, Breuer CK, Tanel RE, Zund G, Miura T, Ma PX, et al. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg. 1995 Dec;60(6 Suppl):S513-6.10.1016/S0003-4975(21)01185-1]Search in Google Scholar
[17. Badylak SF, Taylor D, Uygun K. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng. 2011 Aug 15;13:27-53.10.1146/annurev-bioeng-071910-12474321417722]Search in Google Scholar
[18. Dahl SL, Koh J, Prabhakar V, Niklason LE. Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant. 2003;12(6):659-66.10.3727/00000000310874713628866947]Search in Google Scholar
[19. Sung HJ, Meredith C, Johnson C, Galis ZS. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials. 2004 Nov;25(26):5735-42.10.1016/j.biomaterials.2004.01.06615147819]Search in Google Scholar
[20. Schaner PJ, Martin ND, Tulenko TN, Shapiro IM, Tarola NA, Leichter RF, et al. Decellularized vein as a potential scaffold for vascular tissue engineering. J Vasc Surg. 2004 Jul;40(1):146-53.10.1016/j.jvs.2004.03.03315218475]Search in Google Scholar
[21. Kajbafzadeh AM, Javan-Farazmand N, Monajemzadeh M, Baghayee A. Determining the optimal decellularization and sterilization protocol for preparing a tissue scaffold of a human-sized liver tissue. Tissue Eng Part C Methods. 2013 Aug;19(8):642-51.10.1089/ten.tec.2012.033423270591]Search in Google Scholar
[22. Nakayama KH, Lee CC, Batchelder CA, Tarantal AF. Tissue specificity of decellularized rhesus monkey kidney and lung scaffolds. PLoS One. 2013;8(5):e64134.10.1371/journal.pone.0064134366147723717553]Search in Google Scholar
[23. DeQuach JA, Yuan SH, Goldstein LS, Christman KL. Decellularized porcine brain matrix for cell culture and tissue engineering scaffolds. Tissue Eng Part A. 2011 Nov;17(21-22):2583-92.10.1089/ten.tea.2010.0724320419721883047]Search in Google Scholar
[24. Sierad LN, Shaw EL, Bina A, Brazile B, Rierson N, Patnaik SS, et al. Functional Heart Valve Scaffolds Obtained by Complete Decellularization of Porcine Aortic Roots in a Novel Differential Pressure Gradient Perfusion System. Tissue Eng Part C Methods. 2015 Dec;21(12):1284-96.10.1089/ten.tec.2015.0170]Search in Google Scholar
[25. Kerrison P, Steinke M. DAPI staining protocol.]Search in Google Scholar
[26. Inno-train Diagnostic GMBH. Manual DNA Extraction with magnetic beads. 2019 (cited 2019); Available from: https://www.inno-train.de/en/products/dna-isolation/bexs-12-ready-dna-kits/.]Search in Google Scholar
[27. Waterbolk TW, Hoendermis ES, den Hamer IJ, Ebels T. Pulmonary valve replacement with a mechanical prosthesis. Promising results of 28 procedures in patients with congenital heart disease. Eur J Cardiothorac Surg. 2006 Jul;30(1):28-32.10.1016/j.ejcts.2006.02.06916730181]Search in Google Scholar
[28. Freling HG, van Slooten YJ, van Melle JP, Ebels T, Hoendermis ES, Berger RM, et al. Pulmonary valve replacement: twenty-six years of experience with mechanical valvar prostheses. Ann Thorac Surg. 2015 Mar;99(3):905-10.10.1016/j.athoracsur.2014.10.03425617228]Search in Google Scholar
[29. Schwedler G, Lindinger A, Lange PE, Sax U, Olchvary J, Peters B, et al. Frequency and spectrum of congenital heart defects among live births in Germany : a study of the Competence Network for Congenital Heart Defects. Clin Res Cardiol. 2011 Dec;100(12):1111-7.10.1007/s00392-011-0355-721909849]Search in Google Scholar
[30. Shebani SO, McGuirk S, Baghai M, Stickley J, De Giovanni JV, Bu’lock FA, et al. Right ventricular outflow tract reconstruction using Contegra valved conduit: natural history and conduit performance under pressure. Eur J Cardiothorac Surg. 2006 Mar;29(3):397-405.10.1016/j.ejcts.2005.11.04016439155]Search in Google Scholar
[31. Boethig D, Horke A, Hazekamp M, Meyns B, Rega F, Van Puyvelde J, et al. A European study on decellularized homografts for pulmonary valve replacement: initial results from the prospective ESPOIR Trial and ESPOIR Registry datadagger. Eur J Cardiothorac Surg. 2019 Sep 1;56(3):503-910.1093/ejcts/ezz054673576330879050]Search in Google Scholar
[32. Arise Hannover. Welcome to Arise. 2019; Available from: http://arise-clinicaltrial.eu/home.html.]Search in Google Scholar